Author

Tommaso Innocenti

HIGHER VOLUME GROWTH RATE IS ASSOCIATED WITH DEVELOPMENT OF WORRISOME FEATURES IN PATIENTS WITH BRANCH DUCT-INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
HIGHER VOLUME GROWTH RATE IS ASSOCIATED WITH DEVELOPMENT OF WORRISOME FEATURES IN PATIENTS WITH BRANCH DUCT-INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS

Tommaso Innocenti  et al.

HIGHER VOLUME GROWTH RATE IS ASSOCIATED WITH DEVELOPMENT OF WORRISOME FEATURES IN PATIENTS WITH BRANCH DUCT-INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
HIGHER VOLUME GROWTH RATE IS ASSOCIATED WITH DEVELOPMENT OF WORRISOME FEATURES IN PATIENTS WITH BRANCH DUCT-INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS

SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB IN IBD IN CLINICAL REMISSION IS ASSOCIATED WITH A LOWER RATE OF DRUG DISCONTINUATION, DRUG OPTIMIZATION, AND REVERSE-SWITCH: AN INTERNATIONAL MULTICENTER STUDY
SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB IN IBD IN CLINICAL REMISSION IS ASSOCIATED WITH A LOWER RATE OF DRUG DISCONTINUATION, DRUG OPTIMIZATION, AND REVERSE-SWITCH: AN INTERNATIONAL MULTICENTER STUDY

Tommaso Innocenti  et al.

Item 1 - 3 / 3
1